Dreyer Scott
Collegium Pharmaceutical, Inc. · EVP & Chief Commercial Officer
Dreyer Scott is listed in filings as EVP & Chief Commercial Officer at Collegium Pharmaceutical, Inc.. This profile follows SEC Form 4 activity through Mar 5, 2026, including sale activity. Recent filings connect the profile to Collegium Pharmaceutical, Inc. (COLL). The current snapshot covers public activity from Feb 12, 2025 to Mar 5, 2026. Reported amounts are shown as $661.4K to $70.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $146k3.6k shares | SellMar 3, 2026 | $40.99 | $36.27 | |
| $2M46.4k shares | SellMar 3, 2026 | $40.36 | $36.27 |